Princy Kumar
Biographic Data
| ID | 7560693 |
|---|---|
| NAME | Princy Kumar |
| GIVEN NAMES | Princy |
| FAMILY NAME | Kumar |
| SIGNATURE | KUMAR P |
| AFFILIATIONS | Georgetown University |
| ORCID | 0000-0002-5994-2727 |
| VERIFIED | Yes |
| TOTAL WORKS | 12 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 12 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the Salsa Study
Patient-reported outcomes (PROs) facilitate communication between patients and providers, enhancing patient-centered care. We report PROs for virologically suppressed people living with HIV-1 who switched to dolutegravir/lamivudine (DTG/3TC) or continued their 3- or 4-drug current antiretroviral regimen (CAR) in the phase 3 SALSA study. Secondary endpoints included change from baseline in HIV Treatment Satisfaction Questionnaire (status version; …
The Association of Mental Health and Substance Use With Retention in HIV Care Among Black Women in Washington, District of Columbia
Body mass index and quality of life in people living with HIV
With advances in the treatment of HIV, people living with HIV (PLWH) are now expected to have a near-normal life expectancy, but challenges remain in the form of substantially poorer health-related quality of life (HRQoL) than the general population. Being overweight or obese may pose an additional burden in PLWH, but few studies have evaluated the relationship between body mass index (BMI) and HRQoL in PLWH. This study aimed to evaluate and desc…
Mixed Methods Analysis of Telehealth Experience, Satisfaction, and Quality of Care During the Covid Pandemic Among Persons with HIV in Washington, DC
Risk of Severe Covid-19 Disease and the Pandemic’s Impact on Service Utilization Among a Longitudinal Cohort of Persons with HIV-Washington, DC
Improvements in Virologic Control Among PWH Over Time: Narrowing the Gap Between Those With and Without STIs
Cancer Incidence and Cancer Screening Practices Among a Cohort of Persons Receiving HIV Care in Washington, DC
I feel empowered”: Women’s perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain
Long-acting injectable antiretroviral therapy has been shown to be non-inferior to daily oral antiretroviral therapy in clinical trials and may soon become part of clinical care. While most trial participants to date have been men, approximately one quarter of ongoing Phase 3 trial participants are women offering an important opportunity to understand how long-acting antiretroviral therapy is perceived and experienced by women. We conducted in-de…
Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials
Identifying Spatial Variation Along the HIV Care Continuum: The Role of Distance to Care on Retention and Viral Suppression
Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care – Washington, DC
One goal of the HIV care continuum is achieving viral suppression (VS), yet disparities in suppression exist among subpopulations of HIV-infected persons. We sought to identify disparities in both the ability to achieve and sustain VS among an urban cohort of HIV-infected persons in care. Data from HIV-infected persons enrolled at the 13 DC Cohort study clinical sites between January 2011 and June 2014 were analyzed. Univariate and multivariate l…
Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in Aids Care…
DESCRIPTION: After HIV diagnosis, timely entry into HIV medical care and retention in that care are essential to the provision of effective antiretroviral therapy (ART). Adherence to ART is among the key determinants of successful HIV treatment outcome and is essential to minimize the emergence of drug resistance. The International Association of Physicians in AIDS Care convened a panel to develop evidence-based recommendations to optimize entry …
No prominent works on this page.
Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in Aids Care…
DESCRIPTION: After HIV diagnosis, timely entry into HIV medical care and retention in that care are essential to the provision of effective antiretroviral therapy (ART). Adherence to ART is among the key determinants of successful HIV treatment outcome and is essential to minimize the emergence of drug resistance. The International Association of Physicians in AIDS Care convened a panel to develop evidence-based recommendations to optimize entry …
Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care – Washington, DC
One goal of the HIV care continuum is achieving viral suppression (VS), yet disparities in suppression exist among subpopulations of HIV-infected persons. We sought to identify disparities in both the ability to achieve and sustain VS among an urban cohort of HIV-infected persons in care. Data from HIV-infected persons enrolled at the 13 DC Cohort study clinical sites between January 2011 and June 2014 were analyzed. Univariate and multivariate l…
Identifying Spatial Variation Along the HIV Care Continuum: The Role of Distance to Care on Retention and Viral Suppression
Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials
Cancer Incidence and Cancer Screening Practices Among a Cohort of Persons Receiving HIV Care in Washington, DC
I feel empowered”: Women’s perspectives on and experiences with long-acting injectable antiretroviral therapy in the USA and Spain
Long-acting injectable antiretroviral therapy has been shown to be non-inferior to daily oral antiretroviral therapy in clinical trials and may soon become part of clinical care. While most trial participants to date have been men, approximately one quarter of ongoing Phase 3 trial participants are women offering an important opportunity to understand how long-acting antiretroviral therapy is perceived and experienced by women. We conducted in-de…
Risk of Severe Covid-19 Disease and the Pandemic’s Impact on Service Utilization Among a Longitudinal Cohort of Persons with HIV-Washington, DC
Improvements in Virologic Control Among PWH Over Time: Narrowing the Gap Between Those With and Without STIs
Body mass index and quality of life in people living with HIV
With advances in the treatment of HIV, people living with HIV (PLWH) are now expected to have a near-normal life expectancy, but challenges remain in the form of substantially poorer health-related quality of life (HRQoL) than the general population. Being overweight or obese may pose an additional burden in PLWH, but few studies have evaluated the relationship between body mass index (BMI) and HRQoL in PLWH. This study aimed to evaluate and desc…
Mixed Methods Analysis of Telehealth Experience, Satisfaction, and Quality of Care During the Covid Pandemic Among Persons with HIV in Washington, DC
Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the Salsa Study
Patient-reported outcomes (PROs) facilitate communication between patients and providers, enhancing patient-centered care. We report PROs for virologically suppressed people living with HIV-1 who switched to dolutegravir/lamivudine (DTG/3TC) or continued their 3- or 4-drug current antiretroviral regimen (CAR) in the phase 3 SALSA study. Secondary endpoints included change from baseline in HIV Treatment Satisfaction Questionnaire (status version; …
The Association of Mental Health and Substance Use With Retention in HIV Care Among Black Women in Washington, District of Columbia
Medicine (12 works) · HIV/AIDS Research and Interventions (10 works) · Internal Medicine (10 works) · Health psychology (6 works) · HIV, Drug Use, Sexual Risk (6 works) · Human immunodeficiency virus (HIV (6 works) · Public health (6 works) · Viral load (6 works) · Antiretroviral therapy (5 works) · Cohort (5 works)